Literature DB >> 4341644

Effect of electric convulsion therapy on urinary excretion of 3', 5' cyclic adenosine monophosphate.

K Hamadah, H Holmes, G B Barker, G C Hartman, D V Perke.   

Abstract

Electric convulsion therapy (E.C.T.) was used in the treatment of 13 women inpatients suffering from depressive symptoms. Twelve of the patients showed a significant increase in urinary excretion of 3', 5' cyclic adenosine monophosphate (cAMP) on the day of treatment, whereas four controls who received all or part of the preliminary treatment but no electric shock showed a reduction. The results of this study are consistent with the hypothesis that the antidepressant action of E.C.T. is mediated through an increased production of cAMP in brain tissue.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4341644      PMCID: PMC1785995          DOI: 10.1136/bmj.3.5824.439

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  Neurohormones on brain adenyl cyclase activity in vivo.

Authors:  W S Chou; A K Ho; H H Loh
Journal:  Nat New Biol       Date:  1971-10-27

2.  Cyclic 3',5'-nucleotide phosphodiesterase: cytochemical localization in cerebral cortex.

Authors:  N T Florendo; R J Barrnett; P Greengard
Journal:  Science       Date:  1971-08-20       Impact factor: 47.728

3.  A kinetic study of the enzymic hydrolysis of adenosine 3':5'-cyclic monophosphate.

Authors:  E N Ramsden
Journal:  Biochem J       Date:  1970-12       Impact factor: 3.857

4.  Urinary adenosine 3',5'-monophosphate excretion in affective disorders.

Authors:  M I Paul; B R Ditzion; G L Pauk; D S Janowsky
Journal:  Am J Psychiatry       Date:  1970-04       Impact factor: 18.112

5.  The effect of electrical stimulation upon the accumulation of adenosine 3',5'-phosphate in isolated cerebral tissue.

Authors:  S Kakiuchi; T W Rall; H McIlwain
Journal:  J Neurochem       Date:  1969-04       Impact factor: 5.372

6.  The assay of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in biological materials by enzymatic radioisotopic displacement.

Authors:  G Brooker; L J Thomas; M M Appleman
Journal:  Biochemistry       Date:  1968-12       Impact factor: 3.162

7.  3',5' cyclic adenosine monophosphate in depression and mania.

Authors:  Y H Abdulla; K Hamadah
Journal:  Lancet       Date:  1970-02-21       Impact factor: 79.321

8.  Measurement of adenosine 3',5'-monophosphate (cyclic AMP) in brain.

Authors:  B R Ditzion; M I Paul; G L Pauk
Journal:  Pharmacology       Date:  1970       Impact factor: 2.547

9.  Stimulated formation of adenosine 3',5'-cyclic phosphate in cerebral cortex: synergism between electrical activity and biogenic amines.

Authors:  H Shimizu; C R Creveling; J Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1970-04       Impact factor: 11.205

10.  The effects of atropine and dyflos on tremor and increase in whole brain acetylcholine produced by injection of oxotremorine in the rat.

Authors:  B Cox; D Potkonjak
Journal:  Br J Pharmacol       Date:  1969-03       Impact factor: 8.739

View more
  5 in total

1.  Letter: Antipsychiatrists and ECT.

Authors:  R B Moyes; I C Moyes
Journal:  Br Med J       Date:  1975-11-01

2.  Cerebrospinal fluid concentration and urinary excretion of cyclic adenosine-3', 5'-monophosphate in various diseases of children.

Authors:  V V Myllylä; E R Heikkinen; S Similä; E Hokkanen; H Vapaatalo
Journal:  Z Kinderheilkd       Date:  1975

3.  The effect of ECT on plasma cyclic nucleotides: a simulated ECT controlled study in melancholic patients.

Authors:  L Lykouras; M Markianos; J Hatzimanolis; C Stefanis
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990

4.  E.C.T. and cAMP excretion.

Authors:  I C Moyes
Journal:  Br Med J       Date:  1972-09-30

Review 5.  Biochemical assessment of antidepressive drugs.

Authors:  K Ghose
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.